
Feature|Podcasts|July 18, 2025
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 1
Author(s)Jeff Hall
In the first of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share their insights on the role of abbreviated breast MRI in breast screening.
Advertisement
Advertisement
Pointing out that there has been a fair amount of “bloat” in many magnetic resonance imaging (MRI) protocols over the years, Habib Rahbar, M.D., said in a
Related to this article

Catch up on the most-well viewed radiology content in October 2026.

In comparison to the RECIST 1.1 criteria, use of the mpMRI-based NacBI-RADS system for evaluating response to neoadjuvant chemotherapy (NAC) for breast cancer offered an 8 percent higher sensitivity and over 26 percent higher specificity.

In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),

In a recent podcast episode, Jack Andrews, MD, discussed the role of PSMA PET in facilitating more targeted, metastasis-directed therapy for prostate cancer and recent phase 4 research comparing PSMA PET agents in men with low PSA values.

In a new podcast episode, Sharmila Dorbala, MD, MPH, shares her insights on recently published phase 3 research examining the use of the PET/CT radiotracer 124I-evuzamitide for bolstering detection of cardiac amyloidosis.

In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, offers pertinent insights into a recent study assessing whether AI models for breast cancer detection and short-term risk prediction can be used interchangeably.
Advertisement
Advertisement


